Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss
- Conditions
- FatigueCachexiaUnspecified Adult Solid Tumor, Protocol Specific
- Registration Number
- NCT00004912
- Lead Sponsor
- Northwestern University
- Brief Summary
RATIONALE: Megestrol helps improve appetite. Exercise may decrease cancer-related fatigue, improve strength, and build up lost muscle tissue. Exercise plus megestrol may be effective treatment for cancer-related weight loss.
PURPOSE: Phase II trial to study the effectiveness of megestrol plus exercise to improve appetite, increase strength, gain lean body tissue, and decrease fatigue in patients who have cancer-related weight loss.
- Detailed Description
OBJECTIVES: I. Determine the effect of megestrol and progressive resistance training on lean body mass, total body weight, functional capacity, appetite, and fatigue in patients with weight loss due to advanced malignancy.
OUTLINE: This is a multicenter study. Patients receive oral megestrol once daily. Patients also begin progressive resistance training 3 days a week. Treatment/exercise continues for 12 weeks in the absence of unacceptable toxicity or progressive weight loss (greater than 5 pounds or 5% or more over first 4 study weeks).
PROJECTED ACCRUAL: A total of 46 patients will be accrued for this study within 1 year.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (6)
University of Arkansas - Department of Geriatrics
🇺🇸North Little Rock, Arkansas, United States
Pacific Shores Medical Group
🇺🇸Long Beach, California, United States
Office of David Cella
🇺🇸Evanston, Illinois, United States
Shands Hospital and Clinics, University of Florida
🇺🇸Gainesville, Florida, United States
Rex Healthcare
🇺🇸Raleigh, North Carolina, United States
Robert H. Lurie Comprehensive Cancer Center, Northwestern University
🇺🇸Chicago, Illinois, United States